Siemens Medical Solutions Recalls SOMATOM X.ceed Software Applications Over Lack of FDA Clearance
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Siemens Medical Solutions USA, Inc. has initiated a voluntary recall of specific software applications for SOMATOM X.ceed CT systems because they lack required FDA 510(k) clearance.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Siemens Medical Solutions USA, Inc. has initiated a voluntary recall to remove specific software applications from certain SOMATOM X.ceed CT systems. The recall was triggered because the applications—syngo.CT Brain Quantification, syngo.CT Vessel Hyperdensities, and syngo.CT ASPECTS—were distributed without receiving the necessary FDA 510(k) clearance.
Which Products Are Affected
The recall affects two units of the SOMATOM X.ceed software applications. The specific identification details are as follows:
- Product Names: syngo.CT Brain Quantification, syngo.CT Vessel Hyperdensities, syngo.CT ASPECTS
- Material Number: 11330002
- UDI-DI: 04056869231051
- Serial Numbers: 125205, 125250
The distribution of these units was worldwide, including the United States (nationwide), Canada, Costa Rica, India, and Israel.
What You Should Do
The firm initiated the recall process by sending notification letters to affected customers on December 19, 2025. Facilities using the SOMATOM X.ceed systems with the specified serial numbers should follow the instructions provided in the firm's letter regarding the removal or disabling of the unauthorized software applications. For further information, users should contact Siemens Medical Solutions USA, Inc. directly.
Why This Matters
This recall is necessary to ensure that all medical software used in clinical settings has undergone the required regulatory review for safety and effectiveness. Using software that has not received FDA 510(k) clearance may pose unknown risks to patient diagnostic accuracy.
Source
This information is based on an official FDA Recall Notice under recall number Z-1239-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.